National Cancer Institute

FY 2011 Research Funding by Research Topic

Cancer Type Funded Amount
Agent Orange/Dioxin Related $904,954
Aging $107,234,735
Alcoholism Research $673,927
Arctic $692,817
Arthritis $726,526
Ataxia Telangiectasia $2,449,605
Autoimmune Diseases $11,233,031
Basic Behavioral and Social Science $92,439,375
Behavioral and Social Science $338,512,920
Biochemical Epidemiology $265,062,562
Bioengineering $162,292,538
Bone Marrow Transplantation $59,761,972
Cancer $5,058,104,978
Cancer Survivorship $264,599,427
Cervical Cancer Education $6,299,530
Chemoprevention $125,927,813
Childhood Cancers $195,529,112
Chronic Myeloproliferative Disorders $41,079,547
Contraception and Reproduction Research $2,921,363
Depression Research $11,448,562
Diabetes $6,352,704
Digestive Diseases $464,562,457
Down Syndrome $853,447
Gene Therapy $67,165,721
Gene Therapy Clinical Trials $10,409,013
Genetic Testing $102,522,607
Herpes - Genital $471,909
Herpes - Other $50,985,548
Inflammatory Bowel Disease $2,633,987
Interferon $7,337,825
Metastasis $404,767,176
Neurofibromatosis $9,365,375
Nuclear Magnetic Resonance Imaging (NMR) $77,151,997
Nursing Oncology $17,371,122
Organ Transplantation Research $77,681,126
Pesticides $1,735,719
Sleep Disorders $8,246,148
Smoking Behavior $87,315,264
Surgery $94,208,542
Taxol $70,884,268
Tuberous Sclerosis $4,768,811